Skip to content

US · AMIX · MEDICAL - DEVICES

Autonomix Medical, Inc. (AMIX) intrinsic value and stock valuation

$0.89as of 2026-11-21 · Mkt cap 6.57M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Autonomix Medical, Inc. DCF and intrinsic value

InvestorsCraft values AMIX with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AMIX’s statements →

Autonomix Medical, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices The Woodlands, TX 77380 autonomix.com

How the business is doing

Fiscal 2022–2026, USD

Revenue
$0.00
20222026
Net income
-$-16.71M
20222026
Free cash flow
-$-12.29M
20222026
Total equity
$5.89M
20222026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2022–2026, USD
20262025202420232022
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-17.03M-$-11.59M-$-12.03M-$-1.99M-$-13.59M
Net income-$-16.71M-$-11.41M-$-15.43M-$-1.99M-$-13.33M
EPSd-$-49.15M-$-142.63M-$-514.33M-$-2.24M-$-444.33M
Operating cash flow-$-12.28M-$-8.26M-$-6.65M-$-1.85M-$-390K
Capital expenditure-$-10K-$-10K-$-20K-$0.00-$0.00
Free cash flow-$-12.29M-$-8.27M-$-6.67M-$-1.85M-$-390K
Total assets$7.6M$9.81M$9.41M$860K$2.05M
Total debt$0.00$0.00$1M$0.00$0.00
Net debt-$-7M-$-9.14M-$-7.61M-$-860K-$-2.04M
Total equity$5.89M$8.1M$7.63M$640K$1.96M
Cash and short-term investments$7M$9.14M$8.61M$860K$2.04M
Income statement
20262025202420232022
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$10K$0.00$0.00$0.00$0.00
Gross profit-$-10K$0.00$0.00$0.00$0.00
Research and development expenses$7.14M$4.72M$2.23M$740K$0.00
Selling, general and administrative expenses$9.89M$6.86M$5.25M$1.25M$13.6M
Other expenses-$-10K$0.00$4.56M$0.00$0.00
Operating expenses$17M$11.6M$12M$1.99M$13.6M
Cost and expenses$17M$11.6M$12M$1.99M$13.6M
Interest income$320K$350K$130K$0.00$0.00
Interest expense$0.00$180K$80K$0.00$220K
Depreciation and amortization$10K$180K$80K$1.99M$13.6M
Ebitda-$-17.03M-$-11.05M-$-15.27M-$-1.99M-$-13.59M
Operating income-$-17.03M-$-11.59M-$-12.03M-$-1.99M-$-13.59M
Total other income/expenses, net$320K$180K-$-3.4M$0.00$270K
Income before tax-$-16.71M-$-11.41M-$-15.43M-$-1.99M-$-13.33M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-16.71M-$-11.41M-$-15.43M-$-1.99M-$-13.33M
Weighted average shares outstanding$340K$80K$30K$890K$30K
Weighted average diluted shares outstanding$340K$80K$30K$890K$30K
Balance sheet
20262025202420232022
Cash and short-term investments$7M$9.14M$8.61M$860K$2.04M
Net receivables$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$7.58M$9.61M$9.39M$860K$2.05M
Property, plant and equipment, net$20K$20K$20K$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$20K$200K$20K$0.00$0.00
Total assets$7.6M$9.81M$9.41M$860K$2.05M
Accounts payable$700K$680K$490K$170K$90K
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$1.71M$1.71M$780K$220K$90K
Long-term debt$0.00$0.00$1M$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$0.00$1M$0.00$0.00
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$1.71M$1.71M$1.78M$220K$90K
Common stock$10K$0.00$20K$10K$10K
Retained earnings-$-67.09M-$-50.38M-$-38.97M-$-23.54M-$-21.55M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$5.89M$8.1M$7.63M$640K$1.96M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$1M$0.00$0.00
Net debt-$-7M-$-9.14M-$-7.61M-$-860K-$-2.04M
Cash flow statement
20262025202420232022
Net income-$-16.71M-$-11.41M-$-15.43M-$-1.99M-$-13.33M
Depreciation and amortization$10K$180K$80K$0.00$0.00
Stock-based compensation$530K$1.63M$0.00$0.00$0.00
Change in working capital-$-110K$1.24M$80K$140K$200K
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$20K$180K$320K$80K$90K
Net cash provided by operating activities-$-12.28M-$-8.26M-$-6.65M-$-1.85M-$-390K
Investments in property, plant and equipment-$-10K-$-10K-$-20K$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-10K-$-10K-$-20K$0.00$0.00
Common stock issued$2.61M$10M$13.7M$680K$1.89M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$10.2M$8.8M$14.4M$680K$2.43M
Net change in cash-$-2.13M$530K$7.74M-$-1.18M$2.04M
Cash at end of period$7M$9.14M$8.61M$860K$2.04M
Operating cash flow-$-12.28M-$-8.26M-$-6.65M-$-1.85M-$-390K
Capital expenditure-$-10K-$-10K-$-20K-$0.00-$0.00
Free cash flow-$-12.29M-$-8.27M-$-6.67M-$-1.85M-$-390K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Autonomix Medical, Inc.

        Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

        CEO
        Bradley A. Hauser
        Employees
        10
        Beta
        -1.30

        Explore

        Frequently asked questions

        What is the intrinsic value of Autonomix Medical, Inc. (AMIX)?

        InvestorsCraft does not currently publish an intrinsic value for AMIX. How the IC value is calculated.

        Is AMIX undervalued?

        InvestorsCraft does not publish an undervaluation signal for AMIX at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.